← All stories
Markets
Aurinia stock falls on Teva patent settlement for voclosporin
2 outlets - including Investing and Financialpost - are covering this story. EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, “Aurinia”) have entered into a settlement agreement with Teva Pharmaceuticals Inc. (“Teva”…
Covered by 2 outlets
All coverage · 2 articles
Investing.com Stock Market
·2h ago
Aurinia stock falls on Teva patent settlement for voclosporin
Financial Post
·2h ago
Aurinia Settles Patent Litigation with Teva
EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, “Aurinia”) have entered into a settlement agreement with Teva Pharmaceuticals Inc. (“Teva”…